These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 1408730)

  • 41. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.
    Lancet; 1996 Oct; 348(9034):1049-54. PubMed ID: 8874455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is neoadjuvant chemotherapy prior to radio-chemotherapy beneficial in T4 anal carcinoma?
    Moureau-Zabotto L; Viret F; Giovaninni M; Lelong B; Bories E; Delpero JR; Pesenti C; Caillol F; de Chaisemartin C; Minsat M; Monges G; Sarran A; Resbeut M
    J Surg Oncol; 2011 Jul; 104(1):66-71. PubMed ID: 21240983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemotherapy in the treatment of anal canal carcinoma.
    Cacheux W; Lievre A; De La Rochefordiere A; Dieumegard B; Cvitkovic F; Labib A; Mitry E; Buecher B
    Dig Liver Dis; 2012 Oct; 44(10):803-11. PubMed ID: 22658644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination chemotherapy and radiotherapy for a locally advanced squamous cell carcinoma of the urethra: a case report.
    Tran LN; Krieg RM; Szabo RJ
    J Urol; 1995 Feb; 153(2):422-3. PubMed ID: 7815606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of epidermoid carcinoma of the anal canal.
    Greenall MJ; Quan SH; Urmacher C; DeCosse JJ
    Surg Gynecol Obstet; 1985 Dec; 161(6):509-17. PubMed ID: 3934775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of cancer of the anal canal with combination radiochemotherapy: apropos of 12 cases].
    Bourry J; Lagrange JL; Chauvel P; François E; Abbes M; Monticelli J
    Bull Cancer; 1990; 77(2):117-21. PubMed ID: 2317581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Squamous cell carcinoma of the anal margin.
    Newlin HE; Zlotecki RA; Morris CG; Hochwald SN; Riggs CE; Mendenhall WM
    J Surg Oncol; 2004 May; 86(2):55-62; discussion 63. PubMed ID: 15112245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy.
    Vuong T; Kopek N; Ducruet T; Portelance L; Faria S; Bahoric B; Devic S
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1394-400. PubMed ID: 17276620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current treatment for localized anal carcinoma.
    Das P; Crane CH; Ajani JA
    Curr Opin Oncol; 2007 Jul; 19(4):396-400. PubMed ID: 17545807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemoradiation for anal squamous cell carcinoma: case report.
    Fiengo L; Ekci B; Tellan G; Marandola M; Redler A
    G Chir; 2011; 32(8-9):365-7. PubMed ID: 22018257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Commentary: Anal cancer - the benefits of evidence-based treatment.
    Hill J
    Colorectal Dis; 2009 Nov; 11(9):914-6. PubMed ID: 19832863
    [No Abstract]   [Full Text] [Related]  

  • 52. Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).
    Meropol NJ; Niedzwiecki D; Shank B; Colacchio TA; Ellerton J; Valone F; Budinger S; Day JM; Hopkins J; Tepper J; Goldberg RM; Mayer RJ
    J Clin Oncol; 2008 Jul; 26(19):3229-34. PubMed ID: 18490648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab.
    Khawandanah M; Baxley A; Pant S
    J Oncol Pharm Pract; 2015 Jun; 21(3):232-7. PubMed ID: 24627343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-agent paclitaxel in advanced anal cancer after failure of cisplatin and 5-fluorouracil chemotherapy.
    Abbas A; Nehme E; Fakih M
    Anticancer Res; 2011 Dec; 31(12):4637-40. PubMed ID: 22199342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
    Ajani JA; Winter KA; Gunderson LL; Pedersen J; Benson AB; Thomas CR; Mayer RJ; Haddock MG; Rich TA; Willett C
    JAMA; 2008 Apr; 299(16):1914-21. PubMed ID: 18430910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case report of long term survivor of metastatic cloacogenic carcinoma of the anal canal with chemotherapy.
    Fayaz S; Vasishta S; Motawy M
    Gulf J Oncolog; 2007 Jul; (2):65-8. PubMed ID: 20084726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimizing outcomes of chemoradiation in the management of squamous cell carcinoma of the anal canal.
    McHaffie DR; Kozak KR
    Oncology (Williston Park); 2010 Apr; 24(5):424-7. PubMed ID: 20480741
    [No Abstract]   [Full Text] [Related]  

  • 58. Management of anal cancer in 2010. Part 2: current treatment standards and future directions.
    Abbas A; Yang G; Fakih M
    Oncology (Williston Park); 2010 Apr; 24(5):417-24. PubMed ID: 20480740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of combined radio-chemotherapy in the management of epidermoid carcinoma of the anal canal.
    Papillon J
    Int J Radiat Oncol Biol Phys; 1990 Nov; 19(5):1217-8. PubMed ID: 2123841
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of the Primary Tumor in Anal Canal Cancers.
    Glynne-Jones R; Rao S
    Surg Oncol Clin N Am; 2017 Jan; 26(1):73-90. PubMed ID: 27889038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.